- Filed
- Oct 12, 2022 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Mar 31, 2022 | 3.82M sh |
| Shares Diluted | Q3 2022 · Feb 28, 2022 | 3.79M sh |
| Shares Diluted | Q3 2022 · Feb 28, 2022 | 3.81M sh |
| Shares Diluted | Q3 2022 · Feb 28, 2021 | 3.76M sh |
| Shares Diluted restated | Q3 2022 · Feb 28, 2021 | 3.76M sh |
| Capex restated | Q3 2022 · Feb 28, 2022 | $252.13K |
| Capex | Q3 2022 · Feb 28, 2021 | $510.32K |
| Operating Cash Flow restated | Q3 2022 · Feb 28, 2022 | −$6.84M |
| Operating Cash Flow | Q3 2022 · Feb 28, 2021 | −$5.66M |
| Long Term Debt | Q3 2022 · Feb 28, 2022 | $1.53M |
| Long Term Debt | Q3 2022 · May 31, 2021 | $3.25M |
| Short Term Debt | Q3 2022 · Feb 28, 2022 | $472.43K |
| Short Term Debt | Q3 2022 · May 31, 2021 | $541.69K |
| Cash And Equivalents | Q3 2022 · Feb 28, 2022 | $2M |
| Cash And Equivalents | Q3 2022 · May 31, 2021 | $4.03M |
| Stockholders Equity restated | Q3 2022 · Feb 28, 2022 | $3.68M |
| Stockholders Equity | Q3 2022 · May 31, 2021 | $3.77M |
| Stockholders Equity | Q3 2022 · Feb 28, 2021 | $7.12M |
| Stockholders Equity | Q3 2022 · May 31, 2020 | $11.89M |
| Current Liabilities restated | Q3 2022 · Feb 28, 2022 | $4.46M |
| Current Liabilities | Q3 2022 · May 31, 2021 | $4.01M |
| Total Liabilities restated | Q3 2022 · Feb 28, 2022 | $16.82M |
| Total Liabilities | Q3 2022 · May 31, 2021 | $17.4M |
| Current Assets restated | Q3 2022 · Feb 28, 2022 | $5.18M |
| Current Assets | Q3 2022 · May 31, 2021 | $6.96M |
| Total Assets restated | Q3 2022 · Feb 28, 2022 | $20.49M |
| Total Assets | Q3 2022 · May 31, 2021 | $21.17M |
| Sga Expense restated | Q3 2022 · Feb 28, 2022 | $3.35M |
| Sga Expense restated | Q3 2022 · Feb 28, 2022 | $11.89M |
| Sga Expense | Q3 2022 · Feb 28, 2021 | $3.31M |
| Sga Expense | Q3 2022 · Feb 28, 2021 | $8.49M |
| Rd Expense restated | Q3 2022 · Feb 28, 2022 | $13.27K |
| Rd Expense restated | Q3 2022 · Feb 28, 2022 | $28.12K |
| Rd Expense | Q3 2022 · Feb 28, 2021 | $21.73K |
| Rd Expense | Q3 2022 · Feb 28, 2021 | $57.06K |
| Net Income restated | Q3 2022 · Feb 28, 2022 | −$1.05M |
| Net Income restated | Q3 2022 · Feb 28, 2022 | −$188.28K |
| Net Income | Q3 2022 · Feb 28, 2021 | −$2.42M |
| Net Income | Q3 2022 · Feb 28, 2021 | −$4.64M |
| Operating Income restated | Q3 2022 · Feb 28, 2022 | −$2.55M |
| Operating Income restated | Q3 2022 · Feb 28, 2022 | −$7.19M |
| Operating Income | Q3 2022 · Feb 28, 2021 | −$2.5M |
| Operating Income | Q3 2022 · Feb 28, 2021 | −$6.27M |
| Gross Profit restated | Q3 2022 · Feb 28, 2022 | $819.69K |
| Gross Profit restated | Q3 2022 · Feb 28, 2022 | $4.73M |
| Gross Profit | Q3 2022 · Feb 28, 2021 | $831.19K |
| Gross Profit | Q3 2022 · Feb 28, 2021 | $2.4M |
| Cost Of Revenue restated | Q3 2022 · Feb 28, 2022 | $1.03M |
| Cost Of Revenue restated | Q3 2022 · Feb 28, 2022 | $3.84M |
| Cost Of Revenue | Q3 2022 · Feb 28, 2021 | $837.25K |
| Cost Of Revenue | Q3 2022 · Feb 28, 2021 | $2.8M |
| Revenue | Q3 2022 · Feb 28, 2022 | $1.85M |
| Revenue | Q3 2022 · Feb 28, 2022 | $8.57M |
| Revenue | Q3 2022 · Feb 28, 2021 | $1.67M |
| Revenue | Q3 2022 · Feb 28, 2021 | $5.21M |